Profiel
Rushmie Nofsinger is currently the Head-Investors & Media at Scholar Rock Holding Corp.
She previously worked as a Media Contact at AMAG Pharmaceuticals, Inc.
Actieve functies van Rushmie Nofsinger
| Bedrijven | Functie | Begin |
|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Investor Relations Contact | 01-12-2021 |
Eerdere bekende functies van Rushmie Nofsinger
| Bedrijven | Functie | Einde |
|---|---|---|
| AMAG PHARMACEUTICALS, INC. | Public Communications Contact | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
AMAG Pharmaceuticals, Inc.
 AMAG Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AMAG Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. Its products include Makena and Feraheme. It focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It also manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. The company was founded on November 9, 1981 and is headquartered in Waltham, MA. | Health Technology |
